Monophosphoryl Lipid A (MPL) Formulations for the Next Generation of Vaccines

ISSN： 1046-2023

Source： Methods, Vol.19, Iss.1, 1999-09, pp. : 103-107

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines

By Hanke Tomáš

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 601-616

Informa Healthcare

Access to resources Recommend Favorite

Monophosphoryl lipid A is an lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology

By Wang David B

Expert Opinion on Biological Therapy, Vol. 13, Iss. 12, 2013-12 ,pp. : 1639-1641

Informa Healthcare

Access to resources Recommend Favorite

Cytoplasmic signalling domains: the next generation

By Bork P. Schultz J. Ponting C.P.

Trends in Biochemical Sciences, Vol. 22, Iss. 8, 1997-08 ,pp. : 296-298

Elsevier

Access to resources Recommend Favorite

The role of cell culture vaccines in the control of the next influenza pandemic

By Audsley J M Tannock G A

Expert Opinion on Biological Therapy, Vol. 4, Iss. 5, 2004-05 ,pp. : 709-717

Informa Healthcare

Access to resources Recommend Favorite

TransMabs: cell-penetrating antibodies, the next generation

By Muller Sybille Zhao Yunfeng Brown Thomas L Morgan Alton C Kohler Heinz

Expert Opinion on Biological Therapy, Vol. 5, Iss. 2, 2005-02 ,pp. : 237-241

Informa Healthcare

Access to resources Recommend Favorite